Search…

Boqi Pharmaceutical-B (02142.HK) spent HK $1.748 million to repurchase 200,000 shares on June 4th.

06/06/2025

Finance Intelligence News: Hengbo Pharmaceuticals-B (02142.HK) announced that it will repurchase 200,000 shares at a cost of 1.748 million Hong Kong dollars on June 4, 2025.

Latest

2 m ago

Abnormal movements in Hong Kong stocks | Ju Zi Biotechnology (02367.HK) fell by more than 3% again, down nearly 30% from its record high. The controversy over the content of Kefumei, a subsidiary, continues.

2 m ago

Wang Chuanfu, the chairman of BYD, stated that in the next 3 to 5 years, a series of smart driving related technologies will be introduced.

4 m ago

The securities sector continues to decline, with Everbright Securities falling by more than 3%, Huaxin Securities falling by more than 2%, Xiangcai Shares, Jinlong Shares, and Dongxing Securities following suit.

6 m ago

Hong Kong stocks fluctuate | S.F. Express (09699.HK) rises nearly 4% again Instant delivery industry demand surges HSBC says market underestimates company's revenue growth momentum.

6 m ago

Football concept stocks have partially rebounded, creating a 5 consecutive limit up for the turf industry together.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services